Exchange transfusion Health Dictionary

See TRANSFUSION – Transfusion of blood.... blood transfusion

The administration of any ?uid into a person’s vein using a drip. This apparatus facilitates a continuous injection in which the ?uid ?ows by force of gravity from a suspended bottle, via a tube that is ?xed to a hollow needle inserted into a vein (usually in the front of the elbow). Saline solution, PLASMA and whole BLOOD (see below) are the most commonly administered ?uids. Saline is used to restore ?uid to a seriously dehydrated individual (see DEHYDRATION) and may be used as a temporary measure in SHOCK due to blood loss while the appropriate type of blood is being obtained for transfusion. Saline may also be useful as a way of administering a regular supply of a drug over a period of time. Plasma is normally used as a temporary measure in the treatment of shock until appropriately matched blood is available or if for any reason, such as for a patient with severe burns, plasma is preferable to blood.

Transfusion of blood is a technique that has been used since the 17th century – although, until the 20th century, with a subsequent high mortality rate. It was only when incompatibility of BLOOD GROUPS was considered as a potential cause of this high mortality that routine blood-testing became standard practice. Since the National Blood Transfusion Service was started in the United Kingdom (in 1946), blood for transfusion has been collected from voluntary, unpaid donors: this is screened for infections such as SYPHILIS, HIV, HEPATITIS and nvCJD (see CREUTZFELDT-JAKOB DISEASE (CJD)), sorted by group, and stored in blood-banks throughout the country.

In the UK in 2004, the National Blood Authority – today’s transfusion service – announced that it would no longer accept donations from anyone who had received a blood transfusion since 1980 – because of the remote possibility that they might have been infected with the PRION which causes nvCJD.

A standard transfusion bottle has been developed, and whole blood may be stored at 2–6 °C for three weeks before use. Transfusions may then be given of whole blood, plasma, blood cells, or PLATELETS, as appropriate. Stored in the dried form at 4–21 °C, away from direct sunlight, human plasma is stable for ?ve years and is easily reconstituted by adding sterile distilled water.

The National Blood Authority prepares several components from each donated unit of blood: whole blood is rarely used in adults. This permits each product, whether plasma or various red-cell concentrates, to be stored under ideal conditions and used in appropriate clinical circumstances – say, to restore blood loss or to treat haemostatic disorders.

Transfusion of blood products can cause complications. Around 5 per cent of transfused patients suffer from a reaction; most are mild, but they can be severe and occasionally fatal. It can be di?cult to distinguish a transfusion reaction from symptoms of the condition being treated, but the safe course is to stop the transfusion and start appropriate investigation.

In the developed world, clinicians can expect to have access to high-quality blood products, with the responsibility of providing blood resting with a specially organised transfusion service. The cause of most fatal haemolytic transfusion reactions is a clerical error due to faulty labelling and/or failure to identify the recipient correctly. Hospitals should have a strict protocol to prevent such errors.

Arti?cial blood Transfusion with blood from donors is facing increasing problems. Demand is rising; suitable blood donors are becoming harder to attract; the processes of taking, storing and cross-matching donor blood are time-consuming and expensive; the shelf-life is six weeks; and the risk of adverse reactions or infection from transfused blood, although small, is always present. Arti?cial blood would largely overcome these drawbacks. Several companies in North America are now preparing this: one product uses puri?ed HAEMOGLOBIN from humans and another from cows. These provide oxygen-carrying capacity, are unlikely to be infectious and do not provoke immunological rejections. Yet another product, called Oxygene®, does not contain any animal or human blood products; it comprises salt water and a substance called per?ubron, the molecules of which store oxygen and absorb carbon dioxide more e?ectively than does haemoglobin. Within 24 hours of being transfused into a person’s bloodstream, per?ubron evaporates and is harmlessly breathed out by the recipient. Arti?cial blood is especially valuable in that it contains no unwanted proteins that can provoke adverse immunological reactions. Furthermore, it is disease-free, lasts for up to three years and is no more expensive than donor blood. It could well take the place of donor blood within a few years.

Autologous transfusion is the use of an individual’s own blood, provided in advance, for transfusion during or after a surgical operation. This is a valuable procedure for operations that may require large transfusions or where a person has a rare blood group. Its use has increased for several reasons:

fear of infection such as HIV and hepatitis.

shortages of donor blood and the rising cost of units of blood.

substantial reduction of risk of incompatible transfusions. In practice, blood transfusion in the UK is

remarkably safe, but there is always room for improvement. So, in the 1990s, a UK inquiry on the Serious Hazards of Transfusion (SHOT) was launched. It established (1998) that of 169 recently reported serious hazards following blood transfusion, 81 had involved a blood component being given to the wrong patient, while only eight were the result of viral or bacterial infections.

There are three ways to use a patient’s own blood in transfusion:

(1) predeposit autologous donation (PAD) – taking blood from a patient before operation and transfusing this blood back into the patient as required during and after operation.

(2) acute normovalaemic haemodilution (ANH) – diluting previously withdrawn blood and thus increasing the volume before transfusion.

(3) perioperative cell salvage (PCS) – the use of centrifugal cell separation on blood saved during an operation, particularly spinal surgery where blood loss may be considerable.

The government has urged NHS trusts to consider the introduction of PCS as a possible adjunct or alternative to banked-blood transfusion. In one centre (Nottingham), PCS has been used in the form of continuous autologous transfusion for several years with success.

Exchange transfusion is the method of treatment in severe cases of HAEMOLYTIC DISEASE OF THE NEWBORN. It consists of replacing the whole of the baby’s blood with Rh-negative blood of the correct blood group for the baby.... transfusion

See TRANSFUSION – Transfusion of blood.... autologous blood transfusion

See TRANSFUSION.... cell salvage transfusion

See TRANSFUSION.... continuous autologous transfusion

Synthetic organic substances, capable of exchanging ions – cationic or anionic – from the contents of the intestine. Originally used in the prevention of OEDEMA, they have been superseded in this role by the modern DIURETICS, and are now used chie?y in the treatment of HYPERKALAEMIA. They are usually taken by mouth or as an ENEMA.... ion exchange resins

Also known as plasmapheresis. The removal of the circulating PLASMA from the patient. It is done by removing blood from a patient and returning the red cells with a plasma expander. The plasma exchange is carried out through an in-dwelling CANNULA in the femoral vein, and the red cells and plasma are separated by a hemonetics separator. Usually a sequence of three or four sessions is undertaken, at each of which 2–3 litres of plasma are removed. The lost plasma can either be replaced by human serum albumin (see ALBUMINS) or a plasma expander.

In autoimmune disorders, disease is due to damage wrought by circulating ANTIBODIES or sensitised lymphocytes (see LYMPHOCYTE). If the disease is due to circulating humoral antibodies, removal of these antibodies from the body should theoretically relieve the disorder. This is the principle on which plasma exchange was used in the management of autoimmune diseases due to circulating antibodies. Such disorders include Goodpasture’s syndrome, SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) and MYASTHENIA GRAVIS. One of the problems in the use of plasma exchange in the treatment of such diseases is that the body responds to the removal of an antibody from the circulation by enhanced production of that antibody by the immune system. It is therefore necessary to suppress this homeostatic response with cytotoxic drugs such as AZATHIOPRINE. Nevertheless, remissions can be achieved in autoimmune diseases due to circulating antibodies by the process of plasma exchange.... plasma exchange

This procedure is sometimes used instead of blood TRANSFUSION. PLASMA – the ?uid part of blood from which the cells have been separated

– may be dried and in powder form kept almost inde?nitely; when wanted it is reconstituted by adding sterile distilled water. In powder form it can be transported easily and over long distances. Transfusion of plasma is especially useful in the treatment of SHOCK. One advantage of plasma transfusion is that it is not necessary to carry out testing of blood groups before using it.... plasma transfusion

A health scheme that enables intravenous drug abusers to exchange used hypodermic needles for new, sterile ones.

The scheme is aimed at reducing the risks of infections, such as HIV and hepatitis, transmitted by the sharing of contaminated needles.... needle exchange

See blood transfusion, autologous.... transfusion, autologous

complex insoluble chemical compounds that may be administered with the diet to alter the *electrolyte balance of the body in the treatment of heart, kidney, and metabolic disorders. For example, in patients on a strict low-sodium diet such resins combine with sodium in the food so that it cannot be absorbed and passes out in the faeces.... cation-exchange resins

(TTTS) a condition in which communicating vessels in the shared placenta of monochorionic twins (see chorionicity) divert blood to one fetus (the recipient) from the other (the donor), resulting in one fetus with increased blood volume and one anaemic fetus. It complicates 15% of monochorionic twin pregnancies, and a system of ultrasound staging has been developed to assess the severity of the syndrome. TTTS is associated with a high perinatal mortality rate. There is significant morbidity and poor neurodevelopmental outcome in surviving infants due to complications of the disease itself and the high preterm birth rate that invariably accompanies this condition. A range of treatments, including *amnioreduction, *septostomy, and laser ablation of the communicating vessels, have led to an improvement in overall perinatal survival rates.... twin-to-twin transfusion syndrome

The use of a person’s own blood, donated earlier, for blood transfusion. Autologous transfusion eliminates the slight but serious risk of contracting a serious infectious illness from contaminated blood. There is no risk of a transfusion reaction occurring as a result of incompatibility between donor and recipient blood. Up to 3.5 litres of blood can be removed and stored in several sessions at least 4 days apart and up to 3 days before planned surgery. Blood may be salvaged during surgery, filtered and returned to the circulation, reducing the need for transfusion of donated blood.... blood transfusion, autologous